SEC FORM 4
$12,330,000.00
Keenova Therapeutics plc (NONE)
Purchase of 137,000 shares at $90.00 per share.
Reporting Persons GOLDENTREE ASSET MANAGEMENT LP · GoldenTree Asset Management LLC · Tananbaum Steven A. · Transaction Code P
Traded Oct 14, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001493152-26-047403 · filed 2026-10-16 · View filing →